Last update 20 Mar 2025

Brelovitug

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Target
Action
inhibitors
Mechanism
HBsAg inhibitors(HBsAg inhibitors)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationPRIME (European Union), Breakthrough Therapy (United States)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis D, ChronicPhase 2
Australia
20 May 2023
Hepatitis D, ChronicPhase 2
Hong Kong
20 May 2023
Hepatitis D, ChronicPhase 2
United Kingdom
20 May 2023
Hepatitis D, ChronicPhase 2
New Zealand
20 May 2023
Hepatitis B, ChronicPhase 2
Australia
01 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Biospace
ManualManual
Phase 2
31
BJT-778 300 mg
(nagvxjiokl) = vbhnbxclyo vkobjwpgav (plhuqhxzah )
Positive
05 Jun 2024
BJT-778 600 mg
(nagvxjiokl) = bryrwxwgae vkobjwpgav (plhuqhxzah )
Phase 1
-
24
BJT-778 75 mg, 300 mg, or 900 mg
(stgqorhwvn) = dbyzpjkjlc jerjpttbxq (qoxfzfjtfj )
Positive
05 Jun 2024
Placebo
-
Phase 2
21
BJT-778 300 mg SC once weekly (QW)
(mxuateqmzt) = joanayuisz khupqapnvb (medfalefux )
Positive
12 May 2024
BJT-778 600 mg SC QW for 12 weeks followed by Q2W
-
Phase 1
-
(tsorccubbp) = None gcmjoqlwwo (dfiodwwltn )
Positive
01 Jun 2023
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free